ABBV vs NVEC · P/E 81, rev $61.16B vs P/E 35, rev $25.9M
AbbVie Inc (ABBV) versus NVE Corporation (NVEC) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
NVE Corporation (NVEC) is a semiconductors company listed on US.
Latest reported ABBV revenue for 2025-12-31 was $61.16B. Net income was $4.23B. Revenue was up 305.0% from 2024-12-31 to 2025-12-31. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported NVEC revenue for 2025-03-31 was $25.9M. Net income was $15.1M. Revenue was down 13.2% from 2024-03-31 to 2025-03-31. NVEC currently screens at market cap $527.6M and trailing P/E 34.7.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. NVEC currently screens at market cap $527.6M and trailing P/E 34.7.
Not investment advice. Open the ABBV and NVEC stock pages for the full models.
Not investment advice.